Venu Holding grants 200,000 stock options to director
Venu Holding Corp director Thomas M. Finke received a board-approved grant of stock options covering 200,000 shares of common stock at a $2.44 exercise price.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Venu Holding Corp director Thomas M. Finke received a board-approved grant of stock options covering 200,000 shares of common stock at a $2.44 exercise price. Of these, 100,000 options vested immediately on July 22, 2026, and 100,000 will vest on the first anniversary; all expire July 22, 2029, leaving him with options on 200,000 shares.
Insider Trade Summary
Grant/Award: 200,000 shares
Grant/Award
1 txn
Insider
Finke Thomas M
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F1, F2 | 200,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 200,000 contracts (Direct)
Footnotes (2)
- F1. The grant of this stock option to the Reporting Person was approved by the board of directors of Venu Holding Corporation (the "Issuer") and is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d)(1) promulgated thereunder.
- F2. Of the 200,000 shares of the Issuer's common stock underlying this option, 100,000 shares vested immediately when the option was granted on July 22, 2026 (the "Grant Date"), and the remaining 100,000 shares will vest on the first anniversary of the Grant Date.
Key Figures
Stock options granted: 200,000 shares
Exercise price: $2.44 per share
Immediate vesting portion: 100,000 shares
+3 more
6 metrics
Stock options granted
200,000 shares
Options to buy common stock granted to Thomas M. Finke on July 22, 2026
Exercise price
$2.44 per share
Conversion or exercise price of the granted stock options
Immediate vesting portion
100,000 shares
Options that vested immediately on the Grant Date July 22, 2026
One-year vesting portion
100,000 shares
Options that will vest on the first anniversary of the Grant Date
Expiration date
July 22, 2029
Options expire if not exercised by this date
Options held after grant
200,000 shares
Total derivative securities following the reported transaction
Key Terms
Stock Option (Right to Buy), Section 16(b), Rule 16b-3(d)(1), Grant Date, +1 more
5 terms
Stock Option (Right to Buy) financial
"Security title reported as "Stock Option (Right to Buy)""
Section 16(b) regulatory
"and is exempt from Section 16(b) of the Securities Exchange Act"
A federal rule that requires company insiders—like officers, directors and large shareholders—to return any profits made from buying and selling the company’s stock within a six-month window. It matters to investors because it discourages short-term trades that could exploit non-public information and helps protect outside shareholders by creating a simple, enforceable way to recover unfair gains, much like a rule stopping someone from flipping a limited-edition item for quick profit after getting early access.
Rule 16b-3(d)(1) regulatory
"pursuant to Rule 16b-3(d)(1) promulgated thereunder"
Grant Date financial
"granted on July 22, 2026 (the "Grant Date")"
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.
vesting financial
"the remaining 100,000 shares will vest on the first anniversary"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Thomas M. Finke report in this Form 4 for VENU?
Thomas M. Finke reported a grant of stock options for 200,000 shares of Venu Holding Corp common stock. The options were approved by the board and are compensation, not a market purchase or sale of existing shares.
What is the exercise price and expiration date of the VENU options?
The stock options have an exercise price of $2.44 per share and an expiration date of July 22, 2029. They give the right to buy Venu common stock at that fixed price until expiration.
How do the VENU stock options granted to Finke vest over time?
Of the 200,000 options, 100,000 vested immediately on July 22, 2026, the Grant Date. The remaining 100,000 options will vest on the first anniversary of that Grant Date, creating a one-year vesting schedule for half the award.
Is Finke’s VENU Form 4 transaction a stock purchase or a compensation grant?
The Form 4 reflects a compensation grant of stock options, coded as an acquisition (A). It is a board-approved award exempt from Section 16(b) under Rule 16b-3(d)(1), not an open-market purchase or sale.
What regulatory treatment applies to Finke’s VENU stock option grant?
The grant is described as exempt from Section 16(b) of the Exchange Act under Rule 16b-3(d)(1). This indicates the award was approved by Venu’s board of directors under a rule designed for insider equity compensation.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates